What Mutual Capital Partners does

Mutual Capital Partners (MCP) is a Cleveland, Ohio-based venture capital firm founded in 2004 by Bill Trainor and Wayne Wallace, focused exclusively on healthcare IT and medical device companies. The firm manages four successive funds (MCPF I through MCPF IV), with Fund IV currently active and having made its first investment in early 2023. MCP invests in early to growth-stage companies located primarily in Ohio and the broader Midwest, deliberately avoiding major tech centers to source differentiated deal flow.

The firm's investment criteria target companies with at least $1 million in run-rate revenue, gross margins of 50% or higher, a strong management team, and at least five reference customers who are renewing or expanding. Typical check sizes range from approximately $11M to $15M, deployed across Series A through Series D rounds and select debt financings. Notable portfolio holdings span Cooler Heads (scalp cooling), iotaMotion (cochlear implant insertion systems), Authenticx (voice analytics), Catalyst OrthoScience (orthopedic implants), Checkpoint Surgical, Elevation Spine, Olio Health (post-acute workflow), Redi.Health, and SPR Therapeutics (pain management), with exits including Cardinal Commerce (Visa, 2016), Cleveland HeartLab (Quest Diagnostics, 2017), TGX Medical Systems (Integra LifeSciences, 2017), OrthoHelix Surgical Designs (Tornier, 2012), and RevLocal (Hibu, 2024). Fund I achieved top-quartile returns.

MCP operates as a limited partnership generating revenue through traditional venture capital fund management economics—management fees on committed and deployed capital plus carried interest on successful exits. The four-person team (two co-founder Managing Directors, one Principal, one Senior Associate) sources deals through direct outreach, network introductions, and partnerships with regional angel funds and economic development entities. The firm does not develop proprietary technology products; its competitive position rests on regional deal flow access, co-investment syndicates with RC Capital, River Cities Capital, Blue Heron Capital, Fulcrum Equity Partners, and Revelation Partners, and a strong historical exit track record within healthcare technology investing.

Name

Mutual Capital Partners

Legal name

Mutual Capital Partners

Website

https://mutualcapitalpartners.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm founded in 2004 that invests in healthcare IT and medical device companies across Ohio and the broader Midwest, managing four successive funds (MCPF I-IV) with a focus on early to growth-stage companies demonstrating strong unit economics.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

• Healthcare venture capital
• Medical device investing
• Healthcare IT funding
• Early-stage growth capital
• Midwest venture capital

Headquarters

HQ city

Westlake

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management: MCP generates revenue through traditional venture capital fund management, including management fees on deployed capital and carried interest (performance fees) on successful portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that manages multiple funds (MCPF I through MCPF IV) investing equity capital into early- and growth-stage healthcare IT and medical device companies, primarily in Ohio and the broader Midwest. The firm provides portfolio companies with capital, fundraising guidance, networking support, and hands-on operational partnership in addition to financial investment. Investment criteria require companies to have $1M+ in run-rate revenue, 50%+ gross margins, a strong management nucleus, at least five reference customers, and a location outside of major tech centers.

Product overview

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that invests in healthcare IT and medical device companies. The firm operates multiple investment funds (MCPF I through MCPF IV) and provides capital, networking, and advisory support to portfolio companies. The firm's investment focus is on healthcare technology companies with strong management teams, at least $1 million in run-rate revenue, and 50%+ gross margins, located primarily in Ohio and the Midwest. As a VC firm, MCP does not offer a technology product; its services are investment capital deployment and portfolio company support.

Differentiator

Problem solved

Functional benefit

Products and services

• Mutual Capital Partners Fund I (MCPF I) MCP's inaugural venture capital fund investing in healthcare IT and medical device companies; deployed capital across portfolio companies and produced top quartile returns with multiple exits. For limited partner investors and healthcare startup founders.
• Mutual Capital Partners Fund IV (MCPF IV) MCP's current active venture capital fund investing in healthcare IT and medical device companies; first investment was the $20M Authenticx Series B in January 2023. For limited partner investors and healthcare startup founders.
• Healthcare IT and Medical Device Investment Capital Equity capital deployment across Series A through Series D rounds in healthcare IT and medical device companies, including recent investments in Authenticx, Cooler Heads, iotaMotion, Catalyst OrthoScience, SPR Therapeutics, Olio Health, Redi.Health, Checkpoint Surgical, and Elevation Spine. For early-to-growth-stage healthcare startups meeting MCP's investment criteria ($1M+ run-rate revenue, 50%+ gross margins, 5+ reference customers, strong management nucleus).

Quantifiable outcome

• Top quartile returns on Fund I

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Rev1 Ventures: Columbus, Ohio-based venture capital firm and startup accelerator operating in the same Ohio/Midwest regional ecosystem as MCP. While Rev1 invests across multiple sectors rather than exclusively healthcare, both firms are anchor regional VCs in Ohio with comparable check sizes.
• CincyTech: Cincinnati-based seed and early-stage venture capital firm investing across Ohio and the broader Midwest. Comparable to MCP's regional focus and stage, though CincyTech is sector-agnostic rather than healthcare-specialized.

Direct peers

• River Cities Capital Funds: Healthcare and technology growth equity firm that has co-invested with MCP on Catalyst OrthoScience ($12.3M Series D), Checkpoint Surgical ($16M), and SPR Therapeutics ($37M). Both firms operate in the healthcare growth equity space with similar investment stages.
• First Analysis: Chicago-based growth equity firm with a strong healthcare vertical. Participated in Checkpoint Surgical's $16M capital raise alongside MCP, and operates with similar stage and sector focus in the healthcare growth equity space.
• Arboretum Ventures: Ann Arbor, Michigan-based healthcare venture capital firm investing in medical devices and healthcare IT. Shares MCP's healthcare-only thesis and Midwest geographic focus, with comparable check sizes and stage preferences.
• Revelation Partners: Healthcare-focused growth equity firm that led SPR Therapeutics' $85M financing ($25M Series D-1 + $60M debt) with MCP as a participating incumbent investor. Operates in the same healthcare growth equity category as MCP.
• Blue Heron Capital: Healthcare-focused growth equity firm that led Authenticx's $20M Series B and Redi Health's $14M Series B with MCP participation. Operates as a healthcare growth investor comparable to MCP's thesis and check sizes.
• RC Capital: Healthcare-focused venture capital firm that has repeatedly co-invested with MCP, including on Catalyst OrthoScience ($15M/$12.3M rounds), SPR Therapeutics ($85M financing), and others. Both firms target healthcare IT and medical device companies with similar deal sizes and stages.
• Fulcrum Equity Partners: Atlanta-based growth equity firm that co-invested with MCP in Olio Health's $13M Series A. Targets healthcare and technology growth opportunities with comparable investment stages.

Broad incumbents

• JumpStart Inc. Cleveland-based venture development organization with a broader Ohio and Northeast Ohio focus. Their JumpStart NEXT Fund participated in Checkpoint Surgical's $16M financing alongside MCP, though JumpStart operates across multiple sectors, not exclusively healthcare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/MCPcleveland
• LinkedInlinkedin.com/company/mutual-capital-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments43 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mutual Capital Partners